Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications

Cell and Tissue Research

Volumn 347, Issue 3, 2012, Pages 689-699

  King, William J ^a   Kouris, Nicholas A ^a   Choi, Siyoung ^a   Ogle, Brenda M ^a   Murphy, William L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adult stem cells; Bioprocessing; Multipotency; Polyethyleneimine; Toxicity

Indexed keywords

DNA; ENDOGLIN;

ARTICLE; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONVIRAL GENE DELIVERY SYSTEM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; DNA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELLS; MICE; NIH 3T3 CELLS; PLASMIDS; POLYETHYLENEIMINE; RECEPTORS, CELL SURFACE; TISSUE ENGINEERING; TRANSFECTION; VIRUSES;

EID: 84862797394     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1297-0     Document Type: Article

References (63)

1. Akhtar S, Benter I (2007) Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Adv Drug Deliv Rev 59:164-182 (Pubitemid 46773052)
2. Anwer K, Barnes MN, Fewell J, Lewis DH, Alvarez RD (2010) Phase- I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Ther 17:360-369
3. Audouy S, Molema G, de Leij L, Hoekstra D (2000) Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J Gene Med 2:465-476
4. Baksh D, Yao R, Tuan RS (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392 (Pubitemid 47106005)
5. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J (1999) The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265:134-139
6. Bolliet C, Bohn MC, Spector M (2008) Non-viral delivery of the gene for glial cell line-derived neurotrophic factor to mesenchymal stem cells in vitro via a collagen scaffold. Tissue Eng Part C Methods 14:207-219
7. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92:7297-7301
8. Brazeau GA, Attia S, Poxon S, Hughes JA (1998) In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm Res 15:680-684 (Pubitemid 28275642)
9. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294 (Pubitemid 27065442)
10. Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E (2000) Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther 7:401-407 (Pubitemid 30156552)
11. Byers BA, Garcia AJ (2004) Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 10:1623-1632 (Pubitemid 40054204)
12. Choosakoonkriang S, Lobo BA, Koe GS, Koe JG, Middaugh CR (2003) Biophysical characterization of PEI/DNA complexes. J Pharm Sci 92:1710-1722 (Pubitemid 36929690)
13. Clamme JP, Azoulay J, Mely Y (2003) Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J 84:1960-1968 (Pubitemid 36322958)
14. Clements BA, Bai J, Kucharski C, Farrell LL, Lavasanifar A, Ritchie B, Ghahary A, Uludag H (2006) RGD conjugation to polyethyleneimine does not improve DNA delivery to bone marrow stromal cells. Biomacromolecules 7:1481-1488 (Pubitemid 43811203)
15. Clements BA, Incani V, Kucharski C, Lavasanifar A, Ritchie B, Uludag H (2007a) A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28:4693-4704 (Pubitemid 47259175)
16. Clements BA, Incani V, Kucharski C, Lavasanifar A, Ritchie B, Uludag H (2007b) A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine (TM) 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28:4693-4704 (Pubitemid 47259175)
17. Dragoo JL, Choi JY, Lieberman JR, Huang J, Zuk PA, Zhang J, Hedrick MH, Benhaim P (2003) Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 21:622-629 (Pubitemid 36758206)
18. Durocher Y, Perret S, Kamen A (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9
19. Eglen RM, Gilchrist A, Reisine T (2008) An overview of drug screening using primary and embryonic stem cells. Comb Chem High Throughput Screen 11:566-572
20. Farrell LL, Pepin J, Kucharski C, Lin X, Xu Z, Uludag H (2007) A comparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm 65:388-397
21. Finsinger D, Remy JS, Erbacher P, Koch C, Plank C (2000) Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther 7:1183-1192 (Pubitemid 30488765)
22. Fischer D, Bieber T, Li YX, Elsasser HP, Kissel T (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16:1273-1279 (Pubitemid 29393618)
23. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557-6563 (Pubitemid 37372335)
24. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
25. Geisse S (2009) Reflections on more than 10 years of TGE approaches. Protein Expr Purif 64:99-107
26. Godbey WT, Wu KK, Mikos AG (1999) Poly(ethylenimine) and its role in gene delivery. J Control Release 60:149-160 (Pubitemid 29335941)
27. Godbey WT, Wu KK, Mikos AG (2001) Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 22:471-480
28. Gwak SJ, Kim BS (2008) Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine. Biotechnol Lett 30:1177-1182
29. Haldankar R, Li DQ, Saremi Z, Baikalov C, Deshpande R (2006) Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors. Mol Biotechnol 34:191-199 (Pubitemid 46030392)
30. Horbinski C, Stachowiak MK, Higgins D, Finnegan SG (2001) Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci 2:2
31. Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, Tabata Y (2006) Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 27:4269-4278 (Pubitemid 44294360)
32. Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ (2005) Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 12:418-426 (Pubitemid 40394294)
33. Iuchi S, Marsch-Moreno M, Velez-DelValle C, Easley K, Kuri- Harcuch W, Green H (2006) An immortalized drug-resistant cell line established from 12-13-day mouse embryos for the propagation of human embryonic stem cells. Differentiation 74:160-166
34. Jo J, Nagaya N, Miyahara Y, Kataoka M, Harada-Shiba M, Kangawa K, Tabata Y (2007) Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng 13:313-322
35. Koch H, Jadlowiec JA, Campbell PG (2005) Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14:621-631 (Pubitemid 43201896)
36. Kunath K, von Harpe A, Fischer D, Peterson H, Bickel U, Voigt K, Kissel T (2003) Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular- weight polyethylenimine. J Control Release 89:113-125 (Pubitemid 36412116)
37. Love Z, Wang F, Dennis J, Awadallah A, Salem N, Lin Y, Weisenberger A, Majewski S, Gerson S, Lee Z (2007) Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med 48:2011-2020 (Pubitemid 350232312)
38. Lucarelli E, Beccheroni A, DonatiD, Sangiorgi L, Cenacchi A,DelVento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P (2003) Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24:3095-3100 (Pubitemid 36944940)
39. Lungwitz U, Breunig M, Blunk T, Gopferich A (2005) Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60:247-266 (Pubitemid 40804565)
40. Madry H, Padera R, Seidel J, Langer R, Freed LE, Trippel SB, Vunjak- Novakovic G (2002) Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage. Hum Gene Ther 13:1621-1630 (Pubitemid 35034682)
41. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS (2004) Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6:483-495 (Pubitemid 38456178)
42. Morrow KJ (2008) Optimizing transient gene expression. Genet Eng News 28:54-59
43. Omidi Y, Barar J, Akhtar S (2005) Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. Curr Drug Deliv 2:429-441 (Pubitemid 41277775)
44. Omidi Y, Hollins AJ, Benboubetra M, Drayton R, Benter IF, Akhtar S (2003) Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells. J Drug Target 11:311-323 (Pubitemid 38081335)
45. Palsson B, Bhatia S (2004) Tissue engineering. Pearson Prentice Hall, Upper Saddle River, NJ
46. Park DJ, Choi JH, Leong KW, Kwon JW, Eun HS (2007) Tissue-engineered bone formation with gene transfer and mesenchymal stem cells in a minimally invasive technique. Laryngoscope 117:1267-1271 (Pubitemid 47015680)
47. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
48. Poh M, Boyer M, Solan A, Dahl SL, Pedrotty D, Banik SS, McKee JA, Klinger RY, Counter CM, Niklason LE (2005) Blood vessels engineered from human cells. Lancet 365:2122-2124 (Pubitemid 40826970)
49. Santos JL, Oramas E, Pego AP, Granja PL, Tomas H (2009) Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J Control Release 134:141-148
50. Saraf A, Hacker MC, Sitharaman B, Grande-Allen KJ, Barry MA, Mikos AG (2008) Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 9:818-827 (Pubitemid 351560471)
51. Shea LD, Smiley E, Bonadio J, Mooney DJ (1999) DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17:551-554 (Pubitemid 29262917)
52. Shin JY, Suh D, Kim JM, Choi HG, Kim JA, Ko JJ, Lee YB, Kim JS, Oh YK (2005) Low molecular weight polyethylenimine for efficient transfection of human hematopoietic and umbilical cord blood-derived CD34+ cells. Biochim Biophys Acta 1725:377-384 (Pubitemid 41393533)
53. Song H, Kwon K, Lim S, Kang SM, Ko YG, Xu Z, Chung JH, Kim BS, Lee H, Joung B, Park S, Choi D, Jang Y, Chung NS, Yoo KJ, Hwang KC (2005) Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 19:402-407
54. Stettler M, Zhang XW, Hacker DL, De Jesus M, Wurm FM (2007) Novel orbital shake bioreactors for transient production of CHO derived IgGs. Biotechnol Prog 23:1340-1346 (Pubitemid 350261869)
55. Sun XD, Jeng L, Bolliet C, Olsen BR, Spector M (2009) Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds. Biomaterials 30:1222-1231
56. Thomas RJ, Chandra A, Liu Y, Hourd PC, Conway PP, Williams DJ (2007) Manufacture of a human mesenchymal stem cell population using an automated cell culture platform. Cytotechnology 55:31-39 (Pubitemid 47622172)
57. Thomas RJ, Hourd PC, Williams DJ (2008) Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J Biotechnol 136:148-155
58. Tousignant JD, Gates AL, Ingram LA, Johnson CL, Nietupski JB, Cheng SH, Eastman SJ, Scheule RK (2000) Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: Plasmid DNA complexes in mice. Hum Gene Ther 11:2493-2513
59. Tseng WC, Haselton FR, Giorgio TD (1999) Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim Biophys Acta 1445:53-64 (Pubitemid 29193207)
60. Tsuchiya H, Kitoh H, Sugiura F, Ishiguro N (2003) Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 301:338-343 (Pubitemid 36279243)
61. Tuvesson O, Uhe C, Rozkov A, Lullau E (2008) Development of a generic transient transfection process at 100 L scale. Cytotechnology 56:123-136
62. Wang Y, Wang M, Abarbanell AM, Weil BR, Herrmann JL, Tan J, Novotny NM, Coffey AC, Meldrum DR (2009) MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells. Surgery 146:198-205
63. Wiethoff CM, Middaugh CR (2003) Barriers to nonviral gene delivery. J Pharm Sci 92:203-217 (Pubitemid 36169293)